Chemomab Therapeutics(CMMB) - 2023 Q3 - Quarterly Report

Chemomab Therapeutics Ltd. and its subsidiaries As of September 30, 2023 Chemomab Therapeutics Ltd. and its subsidiaries Condensed Consolidated Interim Balance Sheets F-3 Condensed Consolidated Interim Statements of Changes in Equity F-5 Notes to the Condensed Consolidated Interim Financial StatementsF-8 - F-11 Contents The accompanying notes are an integral part of the condensed consolidated interim financial statements (*) 1 American Depositary Share (ADS) represents 20 Ordinary Shares The accompanying no ...